English
Arabic
GLIRIPI – Leuprolide Depot 3.75 Injection
Leuprolide Depot 3.75 mg Injection
Brand Name: GLIRIPI
Dosage Form – Combo Kit Injection
Accreditations: EU-GMP, WHO-GMP
Market Authorization: MBA Pharmaceuticals Pvt Ltd
Product by:
MBA Pharmaceuticals Pvt. Ltd.
Description
GLIRIPI – Leuprolide Depot 3.75 mg Injection
Leuprolide Depot 3.75 Injection is used in the treatment of prostate cancer. It is also used to treat endometriosis (endometrium of the uterus grows excessively and causes symptoms like pain, heavy or irregular periods), uterine fibroids and central precocious puberty (very early puberty).
Uses of GLIRIPI Injection
- Prostate cancer
- Endometriosis
- Uterine fibroids
- Precocious puberty (premature puberty)
Benefits of GLIRIPI Injection
In Prostate cancer
Prostate cancer is a common cancer in men that often depends on testosterone to grow. Leuprolide 3.75 Injection is used to lower testosterone levels, helping to slow or stop the growth of prostate cancer cells. It supports better disease control and improves outcomes when combined with other therapies.
Reviews
There are no reviews yet.